EP2906253
Pýrrólóbensódíasepín and-PSMA mótefnissamsetning
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
11.10.2013EP published:
1.8.2018EP application number:
13795435.0
EP translation filed:
19.9.2018Grant published:
15.10.2018EPO information:
European Patent Register
Max expiry date:
10.10.2033Expiry date:
10.10.2020
Title:
PYRROLOBENZODIAZEPINE - ANTI-PSMA ANTIBODY CONJUGATES
Timeline
Today
11.10.2013EP application
1.8.2018EP Publication
19.9.2018Translation submitted
15.10.2018Registration published
10.10.2020Expires
Owner
Name:
ADC Therapeutics SAAddress:
Route de la Corniche 3B, 1066, Epalinges, CH
Name:
Medimmune LimitedAddress:
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, GB
Inventor
Name:
VAN BERKEL, Patricius Hendrikus CornelisAddress:
Lausanne, CH
Name:
HOWARD, Philip WilsonAddress:
LondonGreater London E1 2AX, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261712924 PDate:
12.10.2012Country:
US
Number:
201261712928 PDate:
12.10.2012Country:
US
Number:
201361784525 PDate:
14.3.2013Country:
US
Number:
201361784460 PDate:
14.3.2013Country:
US
Number:
201361784477 PDate:
14.3.2013Country:
US
Classification
Categories:
A61K 47/68, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 28.9.2018
Expires: 10.10.2019
Payer: Árnason Faktor
Number: 7
Paid: 4.10.2019
Expires: 10.10.2020
Payer: Árnason Faktor